Virtus ETF Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Sell |
2,846
-8,760
| -75% | -$123K | 0.05% | 259 |
|
|
2025
Q1 | $182K | Buy |
11,606
+5,803
| +100% | +$90.8K | 0.24% | 104 |
|
|
2024
Q4 | $80.8K | Sell |
5,803
-4,064
| -41% | -$56.6K | 0.03% | 342 |
|
|
2024
Q3 | $91.8K | Buy |
9,867
+175
| +2% | +$1.63K | 0.04% | 389 |
|
|
2024
Q2 | $90.1K | Buy |
+9,692
| New | +$90.1K | 0.04% | 356 |
|
|
2023
Q4 | – | Sell |
-9,248
| Closed | -$49.1K | – | 432 |
|
|
2023
Q3 | $49.1K | Sell |
9,248
-924
| -9% | -$4.91K | 0.03% | 415 |
|
|
2023
Q2 | $96.9K | Buy |
10,172
+4,084
| +67% | +$38.9K | 0.06% | 397 |
|
|
2023
Q1 | $67K | Sell |
6,088
-2,335
| -28% | -$25.7K | 0.04% | 407 |
|
|
2022
Q4 | $125K | Buy |
8,423
+3,148
| +60% | +$46.6K | 0.07% | 407 |
|
|
2022
Q3 | $101K | Buy |
5,275
+43
| +0.8% | +$823 | 0.04% | 420 |
|
|
2022
Q2 | $111K | Sell |
5,232
-5,127
| -49% | -$109K | 0.04% | 403 |
|
|
2022
Q1 | $200K | Sell |
10,359
-606
| -6% | -$11.7K | 0.09% | 198 |
|
|
2021
Q4 | $227K | Buy |
10,965
+3,661
| +50% | +$75.8K | 0.09% | 194 |
|
|
2021
Q3 | $174K | Sell |
7,304
-388
| -5% | -$9.24K | 0.08% | 302 |
|
|
2021
Q2 | $210K | Sell |
7,692
-2,610
| -25% | -$71.3K | 0.09% | 310 |
|
|
2021
Q1 | $298K | Buy |
10,302
+185
| +2% | +$5.35K | 0.13% | 241 |
|
|
2020
Q4 | $285K | Sell |
10,117
-1,964
| -16% | -$55.3K | 0.12% | 234 |
|
|
2020
Q3 | $354K | Sell |
12,081
-1,637
| -12% | -$48K | 0.19% | 185 |
|
|
2020
Q2 | $415K | Buy |
+13,718
| New | +$415K | 0.2% | 185 |
|